WS #11595

From 499 msgs · 5 key-dev

Vertex Pharmaceuticals agreed to acquire Crinetics for $85/share (~$10B), sending CRNX up ~99% and highlighting M&A in biotech.

Vertex Acquires Crinetics Pharmaceuticals

Vertex Pharmaceuticals agreed to acquire Crinetics for $85/share (~$10B), sending CRNX up ~99% and highlighting M&A in biotech.

Full world state #11595